Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: ImmunoGen, Inc.
Condition: Small Cell Lung Cancer
NCT01237678
A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
Study was stopped early due to lack of efficacy signal and safety concerns